Activity, safety and circulating tumour DNA (ctDNA) dynamics of paradox breaker BRAF inhibitor PLX8394 in patients with advanced cancer

被引：2

作者：

Gouda, M. A. ^{[1
]}

Sherman, E. J. ^{[2
]}

Gilcrease, G. W. ^{[3
]}

Vaishampayan, U. N. ^{[4
]}

Parikh, A. ^{[5
]}

Feun, L. ^{[6
]}

Kummar, S. ^{[7
]}

Huang, H. ^{[1
]}

Zhang, C. ^{[8
]}

Severson, P. ^{[8
]}

Inokuchi, K. ^{[8
]}

Silverman, M. ^{[8
]}

Bollag, G. ^{[8
]}

Janku, F. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA

[2] Mem Sloan Kettering Canc Ctr, Med Oncol, 1275 York Ave, New York, NY 10021 USA

[3] Huntsman Canc Inst, Med Oncol, Salt Lake City, UT USA

[4] Univ Michigan, Div Hematol Oncol, Michigan Med, Ann Arbor, MI 48109 USA

[5] Massachusetts Gen Hosp, Med Oncol, Boston, MA 02114 USA

[6] Sylvester Comprehens Canc Ctr, Hematol Oncol, Miami, FL USA

[7] Stanford Univ, Med Oncol, Palo Alto, CA 94304 USA

[8] Plexxikon Inc, Berkeley, CA USA

来源：

ANNALS OF ONCOLOGY | 2020年 / 31卷

关键词：

D O I：

10.1016/j.annonc.2020.08.643

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

529MO

引用

页码：S465 / S465

页数：1

共 50 条

[41] Non-invasive genotyping of locally advanced rectal cancer patients using circulating tumour DNA
Toomey, S.
Sartori, A.
Irwin, D.
Carr, A.
Armstrong, P.
Farrelly, A.
O'Sullivan, L.
Bradshaw, S.
Smyth, R.
Workman, J.
Lee, C. L.
O'Neill, B.
Hennessy, B.
CLINICAL & EXPERIMENTAL METASTASIS, 2018, 35 (03) : 185 - 185
[42] Cell-free circulating tumour DNA (ctDNA) in the management of patients (pts) with non-biopsiable (Bx) advanced non-small cell lung cancer (NSCLC).
Kushnir, MArina
Murias, Carmen
Winter, Helen
Bain, Param
Abbosh, Christopher
Papadatos, Dionysis
Newsom-Davis, Thomas
Ahmad, Tanya
Swanton, Charles
Forster, Martin David
Moore, David Allan
Bennett, Philip
Faull, Iris
Lanman, Richard B.
Arkenau, Hendrik-Tobias
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[43] Dynamic circulating tumor DNA (ctDNA) in monitoring trastuzumab deruxtecan (TDXd) activity for patients (pts) with advanced breast cancer: Preliminary results of a feasibility study.
Giordani, Elena
Palazzo, Antonella
Minucci, Angelo
Pavese, Francesco
Paris, Ida
De Paolis, Elisa
Ricciardi, Elena
Orlandi, Armando
Pannunzio, Sergio
Tiberi, Giordana
Carbognin, Luisa
Bria, Emilio
Giannarelli, Diana
Scambia, Giovanni
Giacomini, Patrizio
Fabi, Alessandra
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[44] Personalized circulating tumor DNA analysis used for ctDNA detection and response monitoring among patients with advanced or recurrent endometrial cancer
Toboni, Michael
Maxwell, Larry
Scalise, Carly Bess
Berman, Tara
Hardesty, Melissa
Ketch, Peter
Hook, Nicole
Bridges, Catherine
Dutta, Punashi
Liu, Minetta
Arend, Rebecca
ElNaggar, Adam
Smitherman, Carson
Secord, Angeles Alvarez
GYNECOLOGIC ONCOLOGY, 2024, 190 : S208 - S209
[45] Utility of circulating tumor DNA (ctDNA) to assess tumor response in patients with locally advanced rectal cancer undergoing neoadjuvant therapy
Chakrabarti, S.
Benrud, R.
Chau, J.
Hall, W.
Shreenivas, A.
Erickson, B.
Peterson, C.
Ridolfi, T.
Miller, J.
Banerjee, A.
Thomas, J.
Sharif, S.
Fei, N.
Ludwig, K.
Olshan, P.
Palsuledesai, C.
Malhotra, M.
Jurdi, A.
Aleshin, A.
Kasi, P.
ANNALS OF ONCOLOGY, 2022, 33 : S260 - S261
[46] Mutational analysis of circulating tumour DNA (ctDNA) in patients with ER+/HER2-advanced breast cancer (ABC) receiving palbociclib (P): Results from the TREnd trial
Malorni, L.
Romagnoli, D.
Benelli, M.
Galardi, F.
Biagioni, C.
Curigliano, G.
Minisini, A. M.
Moretti, E.
Risi, E.
De Luca, F.
McCartney, A.
Di Leo, A.
Biganzoli, L.
Migliaccio, I.
ANNALS OF ONCOLOGY, 2021, 32 : S24 - S24
[47] MICRODROPLET DIGITAL PCR FOR THE LONGITUDINAL MONITORING OF CIRCULATING TUMOUR DNA BIOMARKERS IN UNSELECTED PATIENTS WITH ADVANCED LUNG CANCER
Karampini, E.
Muhith, A.
Farah, H.
King, J.
Cane, P.
Spicer, J.
McCaughan, F.
THORAX, 2015, 70 : A59 - A60
[48] Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients
Liao, Hao
Zhang, Jiayang
Zheng, Tiantian
Liu, Xiaoran
Zhong, Jianxin
Shao, Bin
Dong, Xiaoxi
Wang, Xiaohong
Du, Pan
King, Bonnie L.
Jia, Shidong
Yu, Jianjun
Li, Huiping
JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
[49] Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients
Hao Liao
Jiayang Zhang
Tiantian Zheng
Xiaoran Liu
Jianxin Zhong
Bin Shao
Xiaoxi Dong
Xiaohong Wang
Pan Du
Bonnie L. King
Shidong Jia
Jianjun Yu
Huiping Li
Journal of Translational Medicine, 20
[50] Analysis of EGFR Mutations Using Circulating Tumour DNA (ctDNA) in Non-Small Cell Lung Cancer Patients in North East Scotland
Scott, P.
Clark, C.
Kerr, K.
Petrie, T.
Nicolson, M.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S808 - S808

← 1 2 3 4 5 →